SIGA Technologies has gained Japanese regulatory approval for TEPOXX (tecovirimat) 200mg capsules, known as TPOXX in the US, ...

"SIGA’s antiviral approved in Japan for orthopoxvirus treatment" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has ...

( MENAFN - IANS) Lusaka, Jan 4 (IANS) Zambia's health authorities have reported the country's fourth case of monkeypox, also ...

Here we describe historical, current and future therapies to treat orthopoxvirus diseases. Scott Parker, Department of Molecular Microbiology & Immunology, Saint Louis University Health Sciences ...

Tecovirimat did not improve time to lesion resolution compared with placebo in patients with mild to moderate mpox disease.

SIGA Technologies receives Japanese approval for Tepoxx for the treatment of orthopoxviruses: New York Saturday, January 4, 2025, 12:00 Hrs [IST] SIGA Technologies, a commercial s ...

A 30-year-old man recently returning from West Africa was confirmed as a new case of mpox in Serbia on Friday. He is also the ...

Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpoxJapan Biotechno Pharma Co., Ltd. engaged as exclusive distribu ...

Mpox, or monkeypox, is a viral illness caused by the monkeypox virus, a species of the genus Orthopoxvirus. The two main types of Mpox are clade I and clade II. While clade I can cause severe ...